Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism

ACS Nano

Volumn 6, Issue 8, 2012, Pages 6578-6591

  Liu, Wen ^a   Li, Xiaoling ^a   Wong, Yum Shing ^b   Zheng, Wenjie ^a   Zhang, Yibo ^a   Cao, Wenqiang ^a   Chen, Tianfeng ^a  

^a JINAN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

5 fluorouracil; apoptosis; cellular uptake; selenium nanoparticles; synergistic effects

Indexed keywords

5-FLUOROURACIL; ANTICANCER ACTIVITIES; APOPTOTIC PATHWAYS; CASPASE INHIBITORS; CELL APOPTOSIS; CELL POPULATIONS; CELLULAR UPTAKE; CHEMOPREVENTIVE; CHEMOTHERAPEUTIC AGENTS; DNA FRAGMENTATION; HUMAN CANCER; HUMAN CANCER CELLS; MELANOMA CELLS; MITOCHONDRIAL MEMBRANE POTENTIAL; PHYSICAL ADSORPTION; PRE-TREATMENT; SELENIUM NANOPARTICLES; SIMPLE METHOD; STABLE STRUCTURES; SURFACE DECORATION; SYNERGISTIC EFFECT;

ADSORPTION; CELL CULTURE; CELL PROLIFERATION; DERMATOLOGY; DISEASES; MOLECULAR BIOLOGY; NANOPARTICLES; ONCOLOGY; SELENIUM;

CELL DEATH;

ANTINEOPLASTIC AGENT; FLUOROURACIL; NANOCAPSULE; SELENIUM;

APOPTOSIS; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; MELANOMA; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DRUG SYNERGISM; FLUOROURACIL; HUMANS; MELANOMA; NANOCAPSULES; SELENIUM; TREATMENT OUTCOME;

EID: 84865576604     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn202452c     Document Type: Article

References (46)

1. Ferlay, J.; Shin, H. R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D. M. Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 2010, 127, 2893-2917
2. Yager, P.; Edwards, T.; Fu, E.; Helton, K.; Nelson, K.; Tam, M. R.; Weigl, B. H. Microfluidic Diagnostic Technologies for Global Public Health Nature 2006, 442, 412-418
3. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as An Emerging Platform for Cancer Therapy Nat. Nanotechnol 2007, 2, 751-760
4. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20
5. Popova, N. V. Perinatal Selenium Exposure Decreases Spontaneous Liver Tumorogenesis in CBA Mice Cancer Lett. 2002, 179, 39-42
6. Redman, C.; Scott, J. A.; Baines, A. T.; Basye, J. L.; Clark, L. C.; Calley, C.; Roe, D.; Payne, C. M.; Nelson, M. A. Inhibitory Effect of Selenomethionine on the Growth of Three Selected Human Tumor Cell Lines Cancer Lett. 1998, 125, 103-110
7. Prokopczyk, B.; Rosa, J. G.; Desai, D.; Amin, S.; Sohn, O. S.; Fiala, E. S.; El-Bayoumy, K. Chemoprevention of Lung Tumorigenesis Induced by a Mixture of Benzo(a)pyrene and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone by the Organoselenium Compound 1,4-Phenylenebis(methylene)selenocyanate Cancer Lett. 2000, 161, 35-46
8. Hu, H.; Li, G. X.; Wang, L.; Watts, J.; Combs, G. F., Jr.; Lu, J. Methylseleninic Acid Enhances Taxane Drug Efficacy against Human Prostate Cancer and Down-Regulates Antiapoptotic Proteins BCL-XL and Survivin Clin. Cancer Res. 2008, 14, 1150-1158
9. Li, S.; Zhou, Y.; Wang, R.; Zhang, H.; Dong, Y.; Ip, C. Selenium Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis through Modulation of Phospho-AKT and its Downstream Substrates Mol. Cancer Ther. 2007, 6, 1031-1038
10. Yang, G. Q.; Xia, Y. M. Studies on Human Dietary Requirements and Safe Range of Dietary Intakes of Selenium in China and Their Application in the Prevention of Related Endemic Diseases Biomed. Environ. Sci. 1995, 8, 187-201
11. Reid, M. E.; Stratton, M. S.; Lillico, A. J.; Fakih, M.; Natarajan, R.; Clark, L. C.; Marshall, J. R. A Report of High-Dose Selenium Supplementation: Response and Toxicities J. Trace Elem. Med. Biol. 2004, 18, 69-74
12. Wang, H.; Zhang, J.; Yu, H. Elemental Selenium at Nano Size Possesses Lower Toxicity without Compromising the Fundamental Effect on Selenoenzymes: Comparison with Selenomethionine in Mice Free Radic. Biol. Med. 2007, 42, 1524-1533
13. Zhang, J.; Wang, X.; Xu, T. Elemental Selenium at Nano Size (Nano-Se) as a Potential Chemopreventive Agent with Reduced Risk of Selenium Toxicity: Comparison with Se-methylselenocysteine in Mice Toxicol. Sci. 2008, 101, 22-31
14. Park, K.; Lee, S.; Kang, E.; Kim, K.; Choi, K.; Kwon, I. C. New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy Adv. Funct. Mater. 2009, 19, 1553-1566
15. Cao, S.; Durrani, F. A.; Rustum, Y. M. Selective Modulation of the Therapeutic Efficacy of Anticancer Drugs by Selenium Containing Compounds against Human Tumor Xenografts Clin. Cancer Res. 2004, 10, 2561-2569
16. Card, J. W.; Magnuson, B. A. A Method to Assess the Quality of Studies That Examine the Toxicity of Engineered Nanomaterials Int. J. Toxicol. 2010, 29, 402-410
17. Zhang, J.; Wang, H.; Yan, X.; Zhang, L. Comparison of Short-Term Toxicity between Nano-Se and Selenite in Mice Life Sci. 2005, 76, 1099-1109
18. Takimoto, C. H.; Graham, M. A.; Lockwood, G.; Ng, C. M.; Goetz, A.; Greenslade, D.; Remick, S. C.; Sharma, S.; Mani, S.; Ramanathan, R. K.; Synold, T. W.; Doroshow, J. H.; Hamilton, A.; Mulkerin, D. L.; Ivy, P.; Egorin, M. J.; Grem, J. L. Oxaliplatin Pharmacokinetics and Pharmacodynamics in Adult Cancer Patients with Impaired Renal Function Clin. Cancer Res. 2007, 13, 4832-4839
19. Martenson, J. A.; Lipsitz, S. R.; Wagner, H., Jr; Kaplan, E. H.; Otteman, L. A.; Schuchter, L. M.; Mansour, E. G.; Talamonti, M. S.; Benson, A. B, 3rd Initial Results of a Phase II Trial of High Dose Radiation Therapy, 5-Fluorouracil, and Cisplatin for Patients with Anal Cancer (E4292): An Eastern Cooperative Oncology Group study Int. J. Radiat. Oncol. Biol. Phys. 1996, 35, 745-749
20. Saif, M. W.; Hashmi, S.; Mattison, L.; Donovan, W. B.; Diasio, R. B. Peripheral Neuropathy Exacerbation Associated with Topical 5-Fluorouracil Anticancer Drugs 2006, 17, 1095-1098
21. Boyer, J.; Maxwell, P. J.; Longley, D. B.; Johnston, P. G. 5-Fluorouracil: Identification of Novel Downstream Mediators of Tumour Response Anticancer Res. 2004, 24, 417-423
22. Kamoshida, S.; Shiogama, K.; Matsuoka, H.; Matsuyama, A.; Shimomura, R.; Inada, K.; Maruta, M.; Tsutsumi, Y. Immunohistochemical Demonstration of Dihydropyrimidine Dehydrogenase in Normal and Cancerous Tissues Acta Histochem. Cytochem. 2003, 36, 471-479
23. Visser, G. W.; Gorree, G. C.; Peters, G. J.; Herscheid, J. D. Tissue Distribution of [18F]-5-Fluorouracil in Mice: Effects of Route of Administration, Strain, Tumour and Dose Cancer Chemother. Pharmacol. 1990, 26, 205-209
24. Thant, A. A.; Wu, Y.; Lee, J.; Mishra, D. K.; Garcia, H.; Koeffler, H. P.; Vadgama, J. V. Role of Caspases in 5-FU and Selenium-Induced Growth Inhibition of Colorectal Cancer Cells Anticancer Res. 2008, 28, 3579-3592
25. Schroeder, C. P.; Goeldner, E. M.; Schulze-Forster, K.; Eickhoff, C. A.; Holtermann, P.; Heidecke, H. Effect of Selenite Combined with Chemotherapeutic Agents on the Proliferation of Human Carcinoma Cell Lines Biol. Trace Elem. Res. 2004, 99, 17-25
26. Fakih, M.; Cao, S.; Durrani, F. A.; Rustum, Y. M. Selenium Protects against Toxicity Induced by Anticancer Drugs and Augments Antitumor Activity: A Highly Selective, New, and Novel Approach for the Treatment of Solid Tumors Clin. Colorectal Cancer 2005, 5, 132-135
27. Kaur, G.; Iqbal, M.; Bakshi, M. S. Biomineralization of Fine Selenium Crystalline Rods and Amorphous Spheres J. Phys. Chem. C 2009, 113, 13670-13676
28. Li, Q.; Chen, T. F.; Yang, F.; Liu, J.; Zheng, W. J. Facile and Controllable One-Step Fabrication of Selenium Nanoparticles Assisted by l -Cysteine Mater. Lett. 2010, 64, 614-617
29. Villanueva, A.; de la Presa, P.; Alonso, J. M.; Rueda, T.; Martinez, A.; Crespo, P.; Morales, M. P.; Gonzalez-Fernandez, M. A.; Valdes, J.; Rivero, G. Hyperthermia HeLa Cell Treatment with Silica-Coated Manganese Oxide Nanoparticles J. Phy. Chem. C 2010, 114, 1976-1981
30. Acharya, S.; Dilnawaz, F.; Sahoo, S. K. Targeted Epidermal Growth Factor Receptor Nanoparticle Bioconjugates for Breast Cancer Therapy Biomaterials 2009, 30, 5737-5750
31. Chauhan, A.; Zubair, S.; Sherwani, A.; Owais, M. Aloe Vera Induced Biomimetic Assemblage of Nucleobase into Nanosized Particles PLoS One 2012, 7, e32049
32. Lozan, V.; Kersting, B. Synthesis, Characterisation and Crystal Structure of a Pd(II) Complex of a Heterocyclic Selenium(IV) Imide Dalton Trans. 2007, 4511-4513
33. McAuley, B.; Cabaniss, S. E. Quantitative Detection of Aqueous Arsenic and Other Oxoanions Using Attenuated Total Reflectance Infrared Spectroscopy Utilizing Iron Oxide Coated Internal Reflection Elements to Enhance the Limits of Detection Anal. Chim. Acta 2007, 581, 309-317
34. Wohlhueter RM, M. R.; Plagemann, P. G. W. Facilitated Transport of Uracil and 5-Fluorouracil, and Permeation of Orotic Acid into Cultured Mammalian Cells J. Cell Physiol. 1980, 104, 309-319
35. Yamamoto, S.; Kawasaki, T. Active Transport of 5-Fluorouracil and Its Energy Coupling in Ehrlich Ascites Tumour Cells J. Biochem. 1981, 90, 635-642
36. Ojugo, A. S.; McSheehy, P. M.; Stubbs, M.; Alder, G.; Bashford, C. L.; Maxwell, R. J.; Leach, M. O.; Judson, I. R.; Griffiths, J. R. Influence of PH on the Uptake of 5-Fluorouracil into Isolated Tumour Cells Br. J. Cancer. 1998, 77, 873-879
37. Wang, F.; Wang, Y. C.; Dou, S.; Xiong, M. H.; Sun, T. M.; Wang, J. Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells ACS Nano 2011, 5, 3679-3692
38. Imani, M.; Lahooti-Fard, F.; Taghizadeh, S. M.; Takrousta, M. Effect of Adhesive Layer Thickness and Drug Loading on Estradiol Crystallization in a Transdermal Drug Delivery System AAPS PharmSciTech 2010, 11, 1268-1275
39. Tallarida, R. J. Drug Synergism: Its Detection and Applications J. Pharmacol. Exp. Ther. 2001, 298, 865-872
40. Sinha, R.; El-Bayoumy, K. Apoptosis Is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds Curr. Cancer Drug Targets 2004, 4, 13-28
41. Van Gurp, M.; Festjens, N.; van Loo, G.; Saelens, X.; Vandenabeele, P. Mitochondrial Intermembrane Proteins in Cell Death Biochem. Biophys. Res. Commun. 2003, 304, 487-497
42. Ghobrial, I. M.; Witzig, T. E.; Adjei, A. A. Targeting Apoptosis Pathways in Cancer Therapy CA Cancer J. Clin. 2005, 55, 178-194
43. Fulda, S.; Debatin, K. M. Extrinsic versus Intrinsic Apoptosis Pathways in Anticancer Chemotherapy Oncogene 2006, 25, 4798-4811
44. Dhanasekaran, A.; Kotamraju, S.; Karunakaran, C.; Kalivendi, S. V.; Thomas, S.; Joseph, J.; Kalyanaraman, B. Mitochondria Superoxide Dismutase Mimetic Inhibits Peroxide-Induced Oxidative Damage and Apoptosis: Role of Mitochondrial Superoxide Free Radic. Biol. Med. 2005, 39, 567-583
45. Apel, K.; Hirt, H. Reactive Oxygen Species: Metabolism, Oxidative Stress, and Signal Transduction Annu. Rev. Plant. Biol. 2004, 55, 373-399
46. Chen, T.; Wong, Y. S. Selenocystine Induces Reactive Oxygen Species-Mediated Apoptosis in Human Cancer Cells Biomed. Pharmacother. 2009, 63, 105-113